Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | SPHK2 | Q9NRA0 | 7/20 | 0.40 |
| ▸ | SPHK1 | Q9NYA1 | 6/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2670080 | 1.00 | TSHR (0.67) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL4356512 | 1.00 | TSHR (0.67) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL27466847 | 1.00 | TSHR (0.67) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL9000977 | 1.00 | TSHR (0.67) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL1377125 | 1.00 | TSHR (0.67) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL16322565 | 1.00 | TSHR (0.67) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL16320791 | 1.00 | TSHR (0.67) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL27660714 | 0.98 | TSHR (0.69) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL28481557 | 0.93 | ALDH1A1 (0.77) | TSHRALDH1A1TDP1SMN1; SMN2SPHK2 | |
| SCHEMBL10585663 | 0.92 | TSHR (0.65) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12606952-B2 | Method for producing modified cellulose fiber, and modified cellulose fiber | KAO CORPORATION (JP) | 2026-04-21 | — | — | US | claimed |
| EP-3189093-B1 | PROCESS FOR THE PREPARATION OF EUGENOL POLYETHERS THAT CAN BE HYDROSILYLATED AND EUGENOL POLYETHERSILOXANES AND USE THEREOF | EVONIK DEGUSSA GMBH (DE) | 2019-10-02 | — | — | EP | claimed |
| US-10407546-B2 | Acrylate-terminated urethane polybutadienes from low-monomer 1:1 monoadducts from reactive olefinic compounds and diisocyanates and hydroxy-terminated polybutadienes for liquid optically clear adhesives (LOCAs) | EVONIK DEGUSSA GMBH (DE) | 2019-09-10 | — | — | US | claimed |
| US-20190100620-A1 | ACRYLATE-TERMINATED URETHANE POLYBUTADIENES FROM LOW-MONOMER 1:1 MONOADDUCTS FROM REACTIVE OLEFINIC COMPOUNDS AND DIISOCYANATES AND HYDROXY-TERMINATED POLYBUTADIENES FOR LIQUID OPTICALLY CLEAR ADHESIVES (LOCAs) | EVONIK DEGUSSA GMBH (DE) | 2019-04-04 | — | — | US | claimed |
| US-20170283554-A1 | PROCESS FOR THE PREPARATION OF EUGENOL POLYETHERS THAT CAN BE HYDROSILYLATED AND EUGENOL POLYETHERSILOXANES AND USE THEREOF | EVONIK DEGUSSA GMBH (DE) | 2017-10-05 | — | — | US | claimed |
| EP-3189093-A1 | PROCESS FOR THE PREPARATION OF EUGENOL POLYETHERS THAT CAN BE HYDROSILYLATED AND EUGENOL POLYETHERSILOXANES AND USE THEREOF | Evonik Degussa GmbH (DE) | 2017-07-12 | — | — | EP | claimed |
| WO-2016034375-A1 | PROCESS FOR THE PREPARATION OF EUGENOL POLYETHERS THAT CAN BE HYDROSILYLATED AND EUGENOL POLYETHERSILOXANES AND USE THEREOF | EVONIK DEGUSSA GMBH (DE) | 2016-03-10 | — | — | WO | claimed |
| JP-6080600-A | — | — | None | — | — | JP | disclosed |
| JP-6048916-A | — | — | None | — | — | JP | disclosed |
| JP-7025837-A | — | — | None | — | — | JP | disclosed |
| US-12606952-B2 | Method for producing modified cellulose fiber, and modified cellulose fiber | KAO CORPORATION (JP) | 2026-04-21 | — | — | US | disclosed |
| CN-114507366-B | Membranes with hydrophobically modified cellulose fibers and oils | 花王株式会社 | 2024-11-08 | — | — | CN | disclosed |
| US-11884798-B2 | Film comprising hydrophobized cellulose fibers and oil | KAO CORPORATION (JP) | 2024-01-30 | — | — | US | disclosed |
| US-4465869-A | Process for the production of glyceryl ethers | KAO CORPORATION (JP) | 1984-08-14 | — | — | US | disclosed |
| EP-0071019-B1 | 2,3-DIALKOXYPROPYL GLYCERYL ETHER AND ITS PREPARATION PROCESS AS WELL AS COSMETIC COMPOSITION CONTAINING SAME | KAO SOAP COMPANY, LTD. (JP) | 1984-05-30 | — | — | EP | disclosed |
| EP-0025302-B1 | ALPHA-MONO(METHYL-BRANCHED ALKYL) GLYCERYL ETHER AND A SKIN CARE COSMETIC COMPOSITION CONTAINING THE SAME | Kao Corporation (JP) | 1983-07-27 | — | — | EP | disclosed |
| EP-0071019-A1 | 2,3-Dialkoxypropyl glyceryl ether and its preparation process as well as cosmetic composition containing same | KAO SOAP COMPANY, LTD. (JP) | 1983-02-09 | — | — | EP | disclosed |
| EP-0066107-A1 | 2-Hydroxy-3-methyl-branched-alkoxypropyl glyceryl ether and cosmetic composition containing same | Kao Corporation (JP) | 1982-12-08 | — | — | EP | disclosed |
| EP-0025302-A1 | Alpha-mono(methyl-branched alkyl) glyceryl ether and a skin care cosmetic composition containing the same | Kao Corporation (JP) | 1981-03-18 | — | — | EP | disclosed |
| US-4224311-A | Disubstituted derivatives of glycerol and cosmetic compositions containing the same as an oily excipient therefor | L'OREAL (FR) | 1980-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606952-B2 | Method for producing modified cellulose fiber, and modified cellulose fiber | MACF1, ADH1C, FGB | TSHR 4529/4885ALDH1A1 1129/4885TDP1 1020/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.